RY

Ravi Yemula

Active Director Director DIN 08833026
DIN 08833026 First appointment Aug 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Yemula

Data last updated:

Ravi Yemula is a Director at Bioveco Pharmaceuticals Private Limited (since 2020). The company operates in Business Services.

DIN 08833026
Primary Designation Director
Industry Business Services
First Appointment 13 Aug 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Aug 20202020Active

Board colleagues of Ravi Yemula

NameDINCompanyDesignation
Bhanukiran Kondukoori08833025Bioveco Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Bioveco Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ravi Yemula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Yemula

Ravi Yemula currently holds 1 directorship: Bioveco Pharmaceuticals Private Limited (Director, since 13 Aug 2020).

Ravi Yemula was first appointed on 13 Aug 2020 as Director at Bioveco Pharmaceuticals Private Limited.

The current boards of Ravi Yemula's companies include Bhanukiran Kondukoori (Bioveco Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available